文献速递临床试验与 GCP医学人工智能与信息学

针对慢性疼痛伴抑郁症状患者的自导互联网干预:随机对照试验研究方案

A self-guided Internet-based intervention for individuals with chronic pain and depressive symptoms: study protocol of a randomized controlled trial.
PubMed 文献 · Trials · 2023-07-11

本研究为随机对照试验方案,计划纳入300名慢性疼痛伴抑郁症状患者,随机分为Lenio/COGITO干预组、抑郁聚焦智能手机应用主动对照组和等待名单对照组。主要结局为干预8周后德国疼痛问卷评估的疼痛损害变化,次要结局包括抑郁症状和疼痛严重程度。

要点

  • Lenio是低门槛、匿名、免费的互联网自助干预,联合COGITO手机应用。
  • 主要结局为8周后DSF评估的疼痛损害(日常生活、空闲时间、工作损害均值)。
  • 次要结局包括抑郁症状和疼痛严重程度的降低。

核心结论

  • Lenio是首批将慢性疼痛与抑郁同时干预并接受实证评估的互联网干预之一,本研究旨在为互联网干预的可行性、有效性和可接受性提供关键信息。

研究设计与样本

  • 随机对照试验,计划纳入300名参与者,随机分为Lenio/COGITO干预组、抑郁聚焦智能手机应用主动对照组和等待名单对照组。
  • 评估时间点为基线、8周干预后(post)和16周随访(follow-up)。

主要发现

  • 主要结局为post评估时DSF(德国疼痛问卷)评估的「疼痛损害」(日常生活、空闲时间、工作损害均值)的降低。
  • 次要结局包括抑郁症状的降低以及疼痛严重程度的降低。

关键数值与推荐

  • 主要结局采用DSF(德国疼痛问卷)评估「疼痛损害」,即日常生活、空闲时间、工作损害的平均值。
  • 试验注册号DRKS-ID DRKS00026722,注册日期2021年10月6日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the existence of evidence-based therapy options for the treatment of chronic pain and comorbid depressive symptoms (e.g., CBT), many individuals remain untreated. Treatment gaps result from a lack of specialists, patient fear of stigmatization, or patient immobility. Internet-based self-help interventions could serve as an anonymous and flexible alternative treatment option. In a pilot study, chronic pain patients with comorbid depressive symptoms who used a generic Internet-based depression program showed a significant reduction in depressive symptoms (but not pain symptoms) compared to a waitlist control group. Based on these findings, we developed the low-threshold, anonymous, and cost-free Internet-based self-help intervention Lenio that is tailored to the specific needs of chronic pain patients with comorbid depressive symptoms. Lenio is accompanied by the smartphone application (app) COGITO designed to increase therapeutic success. With Lenio and COGITO addressing both chronic pain and depressive symptoms, the trial aims to increase treatment effects of online interventions for chronic pain patients by reducing both depressive symptoms and pain. METHODS: The effectiveness of the Internet-based self-help intervention and accompanying smartphone app will be evaluated in a randomized controlled trial (RCT). A total of 300 participants will be randomized into an intervention group (Lenio/COGITO), an active control group (depression-focused smartphone app), or a waitlist control group. Assessments will be done at baseline, after an 8-week intervention period (post), and after 16 weeks (follow-up). The primary outcome is the post-assessment reduction in "pain impairment" (mean value of impairment in daily life, free time, and work) as assessed by the DSF (German pain questionnaire). Secondary outcomes will include the reduction in depressive symptoms as well as in the severity of pain. DISCUSSION: Lenio is one of the first Internet-based interventions to reduce chronic pain and depression that will be empirically evaluated. Internet-based interventions could offer a promising alternative to conventional face-to-face psychotherapy in the treatment of chronic pain patients. The primary objective of the current study is to add essential insight into the feasibility, effectiveness, and acceptance of Internet-based interventions for people with chronic pain and depressive symptoms. TRIAL REGISTRATION: DRKS-ID DRKS00026722, Registered on October 6th, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Borsutzky S, Moritz S, Hottenrott B, et al. A self-guided Internet-based intervention for individuals with chronic pain and depressive symptoms: study protocol of a randomized controlled trial. Trials. 2023. PMID: 37434163. doi:10.1186/s13063-023-07440-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。